PLA2R1 and cancer: To this end, all 16 (5.3%) patients, who had a diagnosis of malignancy made within 2 years of MN diagnosis and who participated in the aforementioned prospective cohort of 302 patients with PLA2R1-associated MN, were included in this analysis.